Valuation: Arcoma AB

Market Cap 12Cr 1.18Cr 1.04Cr 97.01L 89.03L 1.67Cr 113.29Cr 1.71Cr 4.5Cr 56Cr 4.44Cr 4.34Cr 193.81Cr P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 7.98Cr 82.06L 72.11L 67.31L 61.77L 1.16Cr 79Cr 1.18Cr 3.12Cr 39Cr 3.08Cr 3.01Cr 134.46Cr EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.21%
Yield 2024 *
-
Yield 2025 -
1 day+0.25%
1 week+1.01%
Current month-9.87%
1 month-3.60%
3 months+7.20%
6 months+10.74%
Current year+9.54%
1 week 7.96
Extreme 7.96
8.34
1 month 7.02
Extreme 7.02
8.96
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
11
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
20.2
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 01/01/2023
Director of Finance/CFO 42 01/01/2022
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Chairman 54 01/01/2017
Director/Board Member 59 01/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+1.01%-20.40%-10.17% 1.18Cr
+2.70%+0.12%-17.00%-21.68% 1.34TCr
+0.07%-3.03%+38.70%-12.31% 398.82Cr
-0.60%+0.19%+63.08%+114.72% 121.22Cr
+1.46%+0.77%-39.11%-59.33% 120.7Cr
+2.46%+3.73%-39.04%-47.00% 110Cr
+2.86%-0.07%-45.23% - 91Cr
-0.61%+1.84%+29.04%+80.83% 47Cr
+0.15%-4.05%+46.04% - 33Cr
-2.71%-8.10%-61.92%+196.20% 25Cr
Average +0.60%-1.50%-4.58%+30.16% 229.21Cr
Weighted average by Cap. +1.83%-0.52%-5.05%-10.98%

Financials

2024 2025
Net sales 16Cr 1.61Cr 1.42Cr 1.32Cr 1.21Cr 2.27Cr 154.43Cr 2.33Cr 6.13Cr 76Cr 6.05Cr 5.92Cr 264.17Cr 13Cr 1.34Cr 1.18Cr 1.1Cr 1.01Cr 1.89Cr 128.81Cr 1.94Cr 5.12Cr 64Cr 5.05Cr 4.94Cr 220.36Cr
Net income 1.12Cr 11.49L 10.1L 9L 9L 16.2L 11Cr 16.59L 43.72L 5.45Cr 43.15L 42.22L 19Cr 50.3L 5L 5L 4L 4L 7L 4.95Cr 7L 19.67L 2.45Cr 19.42L 19L 8.47Cr
Net Debt -1.33Cr -13.69L -12.03L -11.23L -10.31L -19.29L -13Cr -19.77L -52.08L -6.49Cr -51.41L -50.29L -22Cr -3.52Cr -36.22L -31.83L -29.71L -27.26L -51.04L -35Cr -52.29L -1.38Cr -17Cr -1.36Cr -1.33Cr -59Cr
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
29/26/29 SEK 8.040 +0.25% 2,500
28/26/28 SEK 8.020 -3.14% 16,684
27/26/27 SEK 8.280 -0.72% 1,910
24/26/24 SEK 8.340 +3.99% 146
23/26/23 SEK 8.020 +0.75% 1,020

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock